Drug firm GlaxoSmithKline has applied for a licence from the European Medicines Agency for the RTS,S vaccine .
It took 30 years to develop the vaccine, which is the first malaria vaccine to reach advanced trials .
Scientists have worked on the vaccine for more than 20 years - at a cost of more than Â£330million .